These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 29992789

  • 1. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
    Jiang Z, Wang X, Li J, Yang H, Lin X.
    J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
    [Abstract] [Full Text] [Related]

  • 2. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
    Saito Y, Takasawa A, Takasawa K, Aoyama T, Akimoto T, Ota M, Magara K, Murata M, Hirohashi Y, Hasegawa T, Sawada N, Saito T, Osanai M.
    Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Kawai K, Uemura M, Munakata K, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Ikenaga M, Murata K, Mizushima T, Yamamoto H, Doki Y, Mori M.
    Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target.
    Chen L, Wu Z, Guo J, Wang X, Zhao Z, Liang H, Zhang R, Deng J.
    Clin Exp Med; 2023 Oct; 23(6):2443-2456. PubMed ID: 36422738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ, Dai FX, Long ZW, Cai H, Liu XW, Zhou Y, Hong Q, Dong QZ, Wang YN, Huang H.
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
    Zhang Y, Qiao HX, Zhou YT, Hong L, Chen JH.
    Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
    [Abstract] [Full Text] [Related]

  • 15. Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer.
    Fu H, Gao H, Qi X, Zhao L, Wu D, Bai Y, Li H, Liu X, Hu J, Shao S.
    Cancer Commun (Lond); 2018 May 08; 38(1):18. PubMed ID: 29764507
    [Abstract] [Full Text] [Related]

  • 16. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.
    Hou XL, Ji CD, Tang J, Wang YX, Xiang DF, Li HQ, Liu WW, Wang JX, Yan HZ, Wang Y, Zhang P, Cui YH, Wang JM, Bian XW, Liu W.
    Sci Rep; 2017 Jun 09; 7(1):3153. PubMed ID: 28600569
    [Abstract] [Full Text] [Related]

  • 17. Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway.
    Lu Y, Zhang Y, Wang X, Zhang H, Zhu Y, Zhang J, Sha H, Zou R, Gan Y, Sui Y, Wang J, Du T, Wu J, Feng J.
    Dis Markers; 2023 Jun 09; 2023():1702125. PubMed ID: 37457886
    [Abstract] [Full Text] [Related]

  • 18. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
    Jia S, Qu T, Wang X, Feng M, Yang Y, Feng X, Ma R, Li W, Hu Y, Feng Y, Ji K, Li Z, Jiang W, Ji J.
    PLoS One; 2017 Jun 09; 12(4):e0175058. PubMed ID: 28422983
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.